- KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
- KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
- KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
- KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- KALA BIO to Participate in Upcoming Investor Conferences in August
- Kala Pharmaceuticals Announces Name Change to KALA BIO
- Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼
Key statistics
On Friday, KALA BIO Inc (KALA:NAQ) closed at 7.01, 37.40% above the 52 week low of 5.10 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.83 |
---|---|
High | 7.01 |
Low | 6.78 |
Bid | 6.95 |
Offer | 7.09 |
Previous close | 6.75 |
Average volume | 6.61k |
---|---|
Shares outstanding | 2.82m |
Free float | 2.31m |
P/E (TTM) | -- |
Market cap | 19.74m USD |
EPS (TTM) | -17.94 USD |
Data delayed at least 15 minutes, as of May 03 2024 20:37 BST.
More ▼